This comprehensive guidance proposes significant changes to the scope of the 340B program that would reduce the opportunity for 340B savings for participating covered entities. Foley invites you to join us on Tuesday, September 22, 2015 for a web conference highlighting some of the key legal complexities and operational challenges raised by the guidance.
We will discuss:
- The impact of proposed changes on the scope of allowable 340B purchases
- What this means for coordinating with Medicaid and other payors
- The operational implications to drug accumulations, program management, and audit readiness
- How this affects compliance oversight and reporting requirements
Speakers
Elizabeth S. Elson, Of Counsel, Foley & Lardner LLP
Anil Shankar, Associate, Foley & Lardner LLP
Karolyn Woo-Miles, Principal, Deloitte & Touche LLP
Christine Farmer, Manager, Deloitte & Touche LLP
There is no cost to participate in this program, but pre-registration is required. We look forward to having you join us. For more information, please contact Christina Wade at [email protected].
* Foley & Lardner LLP will apply for CLE credit after the program, wherever applicable. Foley & Lardner LLP certifies that this activity has been approved for California MCLE credits by the State Bar of California. Foley & Lardner LLP is a State Bar of California MCLE approved provider. New York licensed attorneys admitted two years or less are not eligible to earn CLE credit through nontraditional formats. This program is appropriate for experienced New York attorneys only. Certificates of attendance will be distributed to eligible participants approximately 8 weeks after the web conference via email.
